Cargando…
Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection
BACKGROUND: Growing evidence has suggested that right-sided colon cancer (RCC) and left-sided colon cancer (LCC) should be considered as different tumor entities. However, stage III colon cancer is currently treated as the same entity with uniform therapy. This study was aimed at investigating the p...
Autores principales: | Peng, Jianhong, Li, Cong, Wang, Fulong, Zhang, Huizhong, Xiao, Weiwei, Li, Hui, Lu, Zhenhai, Pan, Zhizhong, Wu, Xiaojun, Zhang, Rongxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054755/ https://www.ncbi.nlm.nih.gov/pubmed/30140160 http://dx.doi.org/10.2147/CMAR.S163520 |
Ejemplares similares
-
High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy
por: Zhou, Wenhao, et al.
Publicado: (2019) -
Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience
por: Peng, Jianhong, et al.
Publicado: (2019) -
Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
por: Pan, Zhizhong, et al.
Publicado: (2018) -
Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer
por: Peng, Jianhong, et al.
Publicado: (2017) -
Outcomes of right-sided and left-sided colon cancer after curative resection
por: Yang, Chien-Yi, et al.
Publicado: (2022)